Netherlands Immunoassay Analyzers Market Size & Outlook
Netherlands immunoassay analyzers market, 2016-2028 (US$M)
Related Markets
Netherlands immunoassay analyzers market highlights
- The Netherlands immunoassay analyzers market generated a revenue of USD 292.7 million in 2021 and is expected to reach USD 490.0 million by 2028.
- The Netherlands market is expected to grow at a CAGR of 7.6% from 2022 to 2028.
- In terms of segment, reagents & kits was the largest revenue generating product in 2021.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Immunoassay analyzers market data book summary
| Market revenue in 2021 | USD 292.7 million |
| Market revenue in 2028 | USD 490.0 million |
| Growth rate | 7.6% (CAGR from 2021 to 2028) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
| Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
Other key industry trends
- In terms of revenue, Netherlands accounted for 1.3% of the global immunoassay analyzers market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, UK immunoassay analyzers market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,884.3 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunoassay Analyzers Market Scope
Immunoassay Analyzers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Netherlands immunoassay analyzers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.31% in 2021. Horizon Databook has segmented the Netherlands immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
The Netherlands spent around USD 90.6 billion on healthcare in 2019 and USD 86.5 billion in 2018. This was equivalent to approximately 10% of GDP in both years, which is comparable to the share of health spending in Norway, Denmark, and the UK. The Netherlands has a high cancer rate in the EU, just behind Ireland and Denmark.
The most commonly occurring cancers are colon cancer, melanoma, and breast cancer concerning its population size. In regards to other European nations, the Netherlands has more common melanoma and colon cancer cases reported in both men and women.
While women are more likely also to develop breast cancer or lung cancer, the incidence rate of prostate cancer in men is also high in the Netherlands than in other nations. According to the data from the Dutch Cancer Registry and Statistics Netherlands (CBS), in 2019, around 117,631 individuals were diagnosed with cancer.
Reasons to subscribe to Netherlands immunoassay analyzers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Netherlands immunoassay analyzers market databook
-
Our clientele includes a mix of immunoassay analyzers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Netherlands immunoassay analyzers market , including forecasts for subscribers. This country databook contains high-level insights into Netherlands immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Netherlands immunoassay analyzers market size, by product, 2016-2028 (US$M)
Netherlands Immunoassay Analyzers Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
